Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-372-500"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-09-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"sl"^^xsd:language2
lpv:document identification number	"en.20120911.32.2-372-500"2
lpv:hasSubsequent	lp_eu:2012-09-11-Speech-2-373-0002
lpv:speaker	lp:Alojz Peterle2
lpv:spokenAs	vice-chair; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-29--2014-06-30)3 member; AFET (2012-01-19--2014-06-30)3 member; EPP (2009-07-14--2014-06-30)3 substitute; Delegation for relations with Iraq (2009-09-16--2014-03-25)3 substitute; ENVI (2012-01-19--2014-06-30)3 unknown; Nova Slovenija - Krščanska ljudska stranka (2009-07-14--2014-03-10)3 member; Delegation to the EU-Croatia Joint Parliamentary Committee (2009-12-14--2013-06-30)3
lpv:translated text	"Trust is good, but control is better. The safety of medicines is in the interest of public health, which requires supervision of pharmacovigilance systems. We cannot allow a repeat of what happened with the Mediator medicine in France, which is believed to have been responsible for between 500 and 2 000 deaths. I support the Commission’s efforts in making further changes to pharmacovigilance legislation. My vote in favour also reflects my wish that patients and health care professionals are more accurately informed about medicines which require additional monitoring."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph